Atlas has acquired Erickson Framing through its newly formed company, Erickson Framing Holdings. Erickson Framing was acquired from Masco Corporation, a producer of home improvement and building products. Erickson is a construction services and pre-fabricated building products company that provides turn-key framing services, framing packages, trusses and other products to builders and developers. Erickson’s primary geographic markets include Arizona, Northern California and the greater Reno, NV area. Erickson was acquired by Masco in 2007. This acquisition reflects Atlas’ investment strategy of purchasing and transitioning divisions of a larger corporate parent into strong, independent companies. While Erickson has struggled through the

In a year defined by low interest rates, buyers continued to look to spend cash reserves on mature acquisition targets, according to SRS | Shareholder Representative Services’ 2012 SRS M&A Deal Terms Study. The new study, which reports on over 200 data points and builds on data from prior SRS studies, covers 342 acquisitions on which SRS served as the shareholder representative, including mergers, asset purchases and stock purchases.  In aggregate, these deals represent USD55.3bn in stated deal value with USD42.7bn paid at closing, USD4.9bn held in escrow and USD7.7bn in defined earn-out consideration.  For the first time, the study

Hogan Lovells has advised AEA Technology on its restructuring and the sale of certain of its businesses including its European consulting business to Ricardo for GBP18m. AEA Europe, which went into administration on 8 November 2012, is an environmental consultancy providing technical consultancy services to the UK public sector, the European Commission, international agencies and private sector organisations. Engineering consultancy Ricardo has acquired the business, operating assets and a staff of approximately 400 located at five UK sites from AEA and will operate as Ricardo-AEA. The Hogan Lovells team advising AEA was led by co-head of private equity Alan Greenough

Willow Laboratories has been acquired by Boston-based private equity firm Ampersand Capital Partners. Willow is a clinical and forensic toxicology laboratory providing urine, hair and saliva testing services to a wide range of healthcare providers including treatment centres, physician practices, and other laboratories.  Using state-of-the-art technology, Willow provides qualitative and quantitative alcohol and drugs-of-abuse test results to aid clients in the diagnosis and treatment of substance abuse. Gail Marcus has joined Willow as president and chief executive officer. Marcus has significant experience building healthcare service organisations and was recently chief executive of Caris Diagnostics (now Miraca Life Sciences), a national

Funds advised by Triton have sold logistics specialist Dematic to private equity investor AEA Investors and Teachers’ Private Capital (TPC), the private equity arm of Canadian pension fund Ontario Teachers’ Pension Plan. As part of the transaction, around EUR450m of outstanding bonds will be redeemed. Dematic has sales of approximately EUR1bn and serves worldwide customers with around 4,500 employees across the globe. The parties to the transaction have agreed not to disclose the purchase price. “Today we are particularly well positioned in the growing retail and e-commerce segments. AEA and TPC have the track record, know-how and capital to support

The aggregate value of technology mergers and acquisitions (M&A) fell 52 per cent year-on-year (YOY) and 15 per cent compared with the previous quarter to USD28.2bn in the third quarter of 2012, according to Ernst & Young’s Global technology M&A update. Large M&A transactions gave way to smaller, more strategic deals, as companies proceeded cautiously in light of continued, widespread macroeconomic uncertainty. In particular, the total volume of announced deals in 3Q12 was 752, up two per cent YOY and three per cent sequentially (on 2Q12). Strategic transactions continue to be driven by five long-term megatrends that are generating disruptive

Synerlab, a French pharmaceutical contract manufacturing firm, and AXA Private Equity have acquired Lyofal and IDD-Tech Orleans. Lyofal, a company founded and managed by Jean-Luc Allemand, specialises in custom-lyophilisation (freeze-drying) while IDD-Tech Orleans specialises in the development of solid dosage forms. With these acquisitions, Synerlab reinforces its leading market position and becomes a company with five sites, employing 700 people, and a turnover of EUR85m. Lyofal’s longstanding expertise and excellent facilities will allow the Synerlab Group to extend its range of products and enter the attractive and growing lyophilization market. Synerlab will also benefit from Lyofal’s strong client portfolio, which